Stephen Basso

Insider Reports History

Entity
Individual
Location
C/O Inozyme Pharma, Inc., 321 Summer Street, Suite 400, Boston, MA
Signature
/s/ Stephen Basso
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Basso:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Innoviva, Inc. Chief Financial Officer Common Stock 12.1K $180K $14.88 Mar 5, 2024 Direct
Innoviva, Inc. Chief Financial Officer Non-statutory Stock Option 176K Mar 5, 2024 Direct
Innoviva, Inc. Chief Financial Officer Nonqualified Stock Option 150K Aug 31, 2023 Direct

Insider Reports Filed by Stephen Basso

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INVA Innoviva, Inc. Mar 5, 2024 2 $180K 4 Mar 7, 2024 Chief Financial Officer
INVA Innoviva, Inc. Aug 31, 2023 1 $0 4 Aug 31, 2023 Chief Financial Officer
INVA Innoviva, Inc. Aug 21, 2023 0 $0 3 Aug 31, 2023 Chief Financial Officer